“…Increasing generation, regulating the types of reactive oxygen species, and inhibiting cellular glutathione peroxidase can break the balance between the production and elimination of ROS in tumor cell and tune the function of intracellular ROS from tumor promoting toward apoptotic signaling, inducing the apoptosis and death of tumor cell for cancer therapeutics (Liou and Storz, 2010 ). In order to enhance the effect of ROS-mediated tumor-specific therapeutic, various drugs and nanomaterials such as doxorubicin, cisplatin, Fe 3 O 4 , gold, silver, polyoxomolybdate (POM), and molybdenum carbide have been studied for targeted delivery to tumor tissues and endocytosis by tumor cells to selectively increase the production of highly toxic ROS in tumor cells (Yanagie et al, 2006 ; He et al, 2012 , 2016b ; Maji et al, 2015 ; Kankala et al, 2017 ; Feng et al, 2019 ; Liu et al, 2019a ; Dong et al, 2020 ; Maiti et al, 2020 ). Among these nanomaterials, ferrite nanoparticles are widely studied due to unique magnetic properties and relatively high safety to human body, especially iron oxide nanoparticles, which have been approved by the US Food and Drug Administration for clinical applications, such as iron supplement, magnetic resonance contrast agent, and drug carrier (Liu et al, 2019c ).…”